Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to AIM ImmunoTech Inc.
Related studies linked through entity extraction aliases.
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
- Status
- COMPLETED
- Phase
- PHASE2
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
- Status
- SUSPENDED
- Phase
- PHASE2
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of FluMist With and Without Ampligen
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects
- Status
- TERMINATED
- Phase
- PHASE2
Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
- Status
- COMPLETED
- Phase
- PHASE2
Ampligen in Chronic Fatigue Syndrome
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
- Status
- TERMINATED
- Phase
- PHASE2